Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catalina Abad

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Medecine Sciences : M/S|November 19, 2025
[Pathophysiology of myositis: inflammation, oxidative stress and mitochondrial dysfunction]Catalina Abad, Olivier Boyer
Current Pharmaceutical Design|April 29, 2011
Immunomodulatory roles of VIP and PACAP in models of multiple sclerosisCatalina Abad, James A Waschek
Journal of Molecular Neuroscience : MN|August 15, 2018
Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout MiceCatalina Abad, Yossan-Var Tan
Current Topics in Medicinal Chemistry|February 4, 2006
Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAPCatalina Abad, Rosa P Gomariz, James A Waschek
Neuroendocrinology|June 20, 2008
Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoidsDawn H Loh, Catalina Abad, Christopher S Colwell, et al.
Brain, Behavior, and Immunity|October 12, 2014
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responsesYossan-Var Tan, Catalina Abad, Yuqi Wang, et al.
Plos One|April 25, 2013
Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAEYossan-Var Tan, Catalina Abad, Yuqi Wang, et al.
Neuroimmunomodulation|October 11, 2014
Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitisCatalina Abad, Gardenia Cheung-Lau, Anne-Claire Coûté-Monvoisin, et al.
Plos One|May 23, 2012
VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responsesCatalina Abad, Yossan-Var Tan, Gardenia Cheung-Lau, et al.
Frontiers in Endocrinology|November 8, 2019
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative DiseasesAlain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Medecine Sciences : M/S|November 19, 2025
[Pathophysiology of myositis: inflammation, oxidative stress and mitochondrial dysfunction]Catalina Abad, Olivier Boyer
Current Pharmaceutical Design|April 29, 2011
Immunomodulatory roles of VIP and PACAP in models of multiple sclerosisCatalina Abad, James A Waschek
Journal of Molecular Neuroscience : MN|August 15, 2018
Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout MiceCatalina Abad, Yossan-Var Tan
Current Topics in Medicinal Chemistry|February 4, 2006
Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAPCatalina Abad, Rosa P Gomariz, James A Waschek
Neuroendocrinology|June 20, 2008
Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoidsDawn H Loh, Catalina Abad, Christopher S Colwell, et al.
Brain, Behavior, and Immunity|October 12, 2014
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responsesYossan-Var Tan, Catalina Abad, Yuqi Wang, et al.
Plos One|April 25, 2013
Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAEYossan-Var Tan, Catalina Abad, Yuqi Wang, et al.
Neuroimmunomodulation|October 11, 2014
Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitisCatalina Abad, Gardenia Cheung-Lau, Anne-Claire Coûté-Monvoisin, et al.
Plos One|May 23, 2012
VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responsesCatalina Abad, Yossan-Var Tan, Gardenia Cheung-Lau, et al.
Frontiers in Endocrinology|November 8, 2019
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative DiseasesAlain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Pageof 5